+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Molecular Diagnostics - Global Strategic Business Report

  • PDF Icon

    Report

  • 880 Pages
  • April 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 338507
The global market for Molecular Diagnostics was valued at US$16.0 Billion in 2024 and is projected to reach US$27.0 Billion by 2030, growing at a CAGR of 9.2% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Molecular Diagnostics market.

Global Molecular Diagnostics Market - Key Trends & Drivers Summarized

What Is Molecular Diagnostics and Why Does It Matter?

Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome - the individual's genetic code and how their cells express their genes as proteins - by applying molecular biology to medical testing. The field has grown significantly with advancements in genomic and proteomic technology, which have revolutionized how diseases are detected, diagnosed, and managed. Molecular diagnostics involves tests that can detect specific sequences in DNA or RNA that may or may not be associated with disease. Tests are often utilized to diagnose infectious diseases, understand a patient’s predisposition to a disease, identify DNA markers for the early detection of cancer, or detect genetic mutations that can drive more personalized treatments. This form of diagnostics is particularly renowned for its ability to rapidly identify and respond to pathogens and mutations, offering the potential for earlier intervention than traditional methods.

How Are Technological Advancements Shaping Molecular Diagnostics?

The technological landscape of molecular diagnostics is rapidly evolving, driven by leaps in areas such as gene sequencing and high-throughput methodologies. Next-generation sequencing (NGS) technologies allow for the simultaneous and rapid sequencing of millions of DNA molecules, greatly reducing the cost and increasing the speed of genetic analysis. This capability is crucial for the development of personalized medicine, where treatments can be tailored to the genetic profiles of individual patients. Additionally, improvements in data analysis tools and bioinformatics support the interpretation of vast amounts of genetic data, turning raw data into actionable medical insights. Digital PCR and CRISPR-based diagnostics are other innovations enhancing the precision and efficiency of molecular tests, allowing for the detection of low-abundance biomarkers and providing high levels of accuracy.

What Are the Key Applications and Implications in Healthcare?

Molecular diagnostics plays a pivotal role in several areas of healthcare, influencing everything from cancer screening to the management of infectious diseases and chronic conditions. In oncology, molecular tests help identify specific biomarkers that guide the use of targeted therapies. For infectious diseases, these diagnostics provide the ability to quickly identify pathogens and their resistance profiles, which is essential for effective treatment and control measures. Furthermore, molecular diagnostics is integral to the advancements in pharmacogenomics, where genetic information is used to predict patient responses to drugs, thereby improving safety and efficacy. The ability to monitor disease progression and response to treatment in real time is another area where molecular diagnostics is becoming indispensable, offering new tools for doctors to manage diseases more effectively.

What Drives the Growth of the Molecular Diagnostics Market?

The growth in the molecular diagnostics market is driven by several factors, including technological advancements, increasing prevalence of infectious diseases and cancer, rising demand for personalized medicine, and greater health awareness among consumers. The integration of high-throughput sequencing technologies has dramatically increased the capability and affordability of genetic testing, making it accessible to a broader population. This accessibility is crucial for the early detection of diseases and for tailoring specific therapies to individuals, which is at the heart of personalized medicine. Additionally, the global rise in health consciousness and preventive healthcare measures has heightened demand for these diagnostics. Governments and healthcare institutions are also recognizing the value of molecular diagnostics in improving health outcomes, leading to greater investment in this technology. Moreover, the ongoing development of more sophisticated data analysis tools has enabled the extraction of more detailed insights from genetic data, further propelling the market forward. These factors collectively ensure sustained growth and continual innovation within the field of molecular diagnostics.

Report Scope

The report analyzes the Molecular Diagnostics market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.

Segments: Component (Reagents & Kits, Instruments, Software & Service); Technology (PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays, Other Technologies); Application (Infectious Disease, Oncology Testing, Genetic Testing, Other Applications).

Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Reagents & Kits segment, which is expected to reach US$16.0 Billion by 2030 with a CAGR of a 9.7%. The Instruments segment is also set to grow at 8.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $6.8 Billion in 2024, and China, forecasted to grow at an impressive 10.5% CAGR to reach $1.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Molecular Diagnostics Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Molecular Diagnostics Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Molecular Diagnostics Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Laboratories, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, Beckman Coulter, Inc., Asuragen, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 84 companies featured in this Molecular Diagnostics market report include:

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Asuragen, Inc.
  • Analytik Jena AG
  • A. Menarini Diagnostics Srl
  • Abaxis, Inc.
  • Agena Bioscience, Inc.
  • Advanced Cell Diagnostics, Inc.
  • AutoGenomics, Inc.
  • Akonni Biosystems, Inc.
  • Berg LLC
  • Agendia, Inc.
  • BioAgilytix Labs

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

  • Tariff-adjusted market forecasts by region and segment
  • Analysis of cost and supply chain implications by sourcing and trade exposure
  • Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

  • Finalized tariff impacts and new trade agreement effects
  • Updated projections reflecting global sourcing and cost shifts
  • Expanded country-specific coverage across the industry

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Molecular Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • Molecular Diagnostics: An Introduction
  • Types of Molecular Diagnostics Tests
  • Market Outlook
  • Major Growth Drivers
  • Developing Countries Offer Strong Growth Prospects
  • PCR Technology Leads the MDx Market
  • Infectious Diseases: The Largest Application Market
  • Reagents and Kits Dominate the Molecular Diagnostics Market
  • Competition
  • Pharmaceutical Firms Carve their Niche in Molecular Diagnostic Market
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Technological Innovations Set to Drive Market Growth
  • New Product Developments
  • Digitalization Trends Benefit Growth
  • Growing Role of Molecular Diagnostics in Personalized Medicine
  • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
  • Companion Diagnostics Drive Personalized Medicine
  • Biomarkers as Companion Diagnostics
  • Oncology-Based Molecular Diagnostics Lead Growth
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • New Applications Hold Promising Potential
  • Next-Generation Sequencing (NGS) Technologies Keep Up the Momentum
  • Rising Emphasis on Lab Automation to Augur Well for Market Growth
  • World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026
  • Nanotechnology for Molecular Diagnostics
  • Growing Popularity of Chemo-Sensitivity Testing of CTCs
  • Genetic Disease Testing Offers Bright Prospects
  • Genetic Testing to Aid in Personalized Medicine
  • Pharmacogenomics Development Augurs Growth of Genetic Testing Market
  • Non-Invasive Prenatal Diagnostics - The Way Ahead
  • Nucleic Acid Amplification Methods for Detection of Antimicrobial Resistance
  • Growing Incidence of Infectious Diseases Spurs Opportunities
  • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
  • PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
  • Rising Incidence of Hospital Acquired Infections Propels Market Growth
  • Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth
  • Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
  • Home HIV Testing Emerges as a Lucrative Option
  • Molecular Tests Gaining Prominence in GC/Chlamydia Testing Market
  • Molecular Diagnostics Opens New Avenues in Viral Hepatitis Testing
  • Hepatitis B prevalence Worldwide by Region
  • HPV Testing: A Fast Growing Segment in the Molecular Diagnostic Testing Market
  • Cervical Cancer: Rising Incidence & Mortality Enhances Need for Testing
  • Molecular based Tests Ingrain Roots in Blood Donor Screening Segment
  • Rise in Healthcare Expenditure to Drive Growth
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2024
  • Aging Population Drives Molecular Diagnostics Market
  • Elderly Healthcare Expenditure as a % of GDP
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 2: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • Table 3: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 5: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • Table 6: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • Table 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Software & Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 11: World Historic Review for Software & Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • Table 12: World 16-Year Perspective for Software & Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 14: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • Table 15: World 16-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for In-Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 17: World Historic Review for In-Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • Table 18: World 16-Year Perspective for In-Situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Isothermal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 20: World Historic Review for Isothermal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • Table 21: World 16-Year Perspective for Isothermal Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 23: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • Table 24: World 16-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Chips & Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 26: World Historic Review for Chips & Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • Table 27: World 16-Year Perspective for Chips & Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 29: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • Table 30: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • Table 31: World Recent Past, Current & Future Analysis for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 32: World Historic Review for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • Table 33: World 16-Year Perspective for Infectious Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • Table 34: World Recent Past, Current & Future Analysis for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 35: World Historic Review for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • Table 36: World 16-Year Perspective for Oncology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • Table 37: World Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 38: World Historic Review for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • Table 39: World 16-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • Table 40: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 41: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • Table 42: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • Table 43: World Molecular Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • Market Analytics
  • Market Overview
  • Infectious Disease Testing Contributes to High Growth
  • Ageing Demographics: Major Driving Factor
  • US Elderly Population: Expected Growth Rates Over the Years 2005-2025
  • Increasing Incidence of Chronic Diseases Drives Focus onto Molecular Diagnostics
  • Rising Incidence of Cancer: A Major Growth Driver
  • Molecular Diagnostics Tests Gain Share in STD Testing Domain
  • HPV Testing Market: A Review
  • Prevalence of HPV in the US by Age
  • US Personalized Medicine Market to Offer Significant Opportunities
  • Companion Diagnostics Market in the US
  • Burgeoning Potential for Genetic Testing
  • Paradigm Shift amongst Consumers Spurs DTC Genetic Testing Market
CANADA
JAPAN
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • Market Overview
  • Brief Note on COVID-19 Testing in Japan
  • Demographics Drive Market Growth
  • Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025
  • Market Analytics
CHINA
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • Market Overview
  • COVID-19 Testing: An Overview
  • HPV Testing in China
  • Market Analytics
EUROPE
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • Market Overview
  • Aging Population: A Prime Growth Driver
  • Automated Systems Gain Preeminence
  • Oncology-based Molecular Diagnostics Holds Immense Potential
  • Number of New Cancer Cases in Europe: 2012, 2018, and 2025
  • HPV Testing in Europe: An Overview
  • Market Analytics
FRANCE
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • Market Overview
  • Healthcare Spending in Asia-Pacific: On the Rise
  • Market Analytics
AUSTRALIA
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • Market Overview
  • Laboratories Pick up on Automation
  • HPV Testing Market: An Overview
  • HPV in India: Breakdown of Type-Distribution and HPV Prevalence
  • Market Analytics
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Asuragen, Inc.
  • Analytik Jena AG
  • A. Menarini Diagnostics Srl
  • Abaxis, Inc.
  • Agena Bioscience, Inc.
  • Advanced Cell Diagnostics, Inc.
  • AutoGenomics, Inc.
  • Akonni Biosystems, Inc.
  • Berg LLC
  • Agendia, Inc.
  • BioAgilytix Labs

Table Information